Latest Press Release on flu vaccine

Dynavax Initiates Large-Scale Phase 3 Trial of HEPLISAV(TM)
BERKELEY, CA -- 02/08/10 -- Dynavax Technologies Corporation (NASDAQ: DVAX) announced today initiation of a large-scale Phase 3 trial designed to demonstrate the lot-to-lot consistency of commercial vaccine and to complete the safety database for H..

---

Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trial
SAN DIEGO - Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today additional interim safety and immunogenicity data from its therapeutic cervical cancer vaccine (VGX-3100) trial. VGX-3100 is a DNA vaccine targeting the E6 an

---

NanoBio Awarded Key Patent Covering Vaccine and Anti-Infective Product Platforms
ANN ARBOR, Mich. - NanoBio Corporation announced today that a sixth U.S. patent covering its novel nanoemulsion technology has been awarded. The patent encompasses composition of matter claims for the company’s lead anti-infective and vaccine product candidates.

---

Sinovac Announces Closing of Common Share Offering
BEIJING, Feb. 2 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA) ("Sinovac" or the "Company"), a leading China-based vaccine manufacturer, announced today that its prev...

---

Inovio Biomedical to Present at BIO CEO & Investor Conference
SAN DIEGO - Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today that Dr. J. Joseph Kim, President and CEO, will present at the 12th Annual BIO CEO & Investor Conference on Monday, February 8th, at 11:30 a.m. ET

---

Nation's First 'Cocoon Strategy' Vaccination Program Delivers 10,000th Immunization
HOUSTON, Feb. 3 /PRNewswire/ -- Physicians from the Center for Vaccine Awareness and Research at Texas Children's Hospital reported that 10,000 Tdap immunizat...

---

Immunovaccine Provides Corporate Update
HALIFAX, NOVA SCOTIA -- 02/04/10 -- Immunovaccine Inc. (TSX VENTURE: IMV) a clinical-stage vaccine development Company, is pleased to provide an update on certain corporate activities. Phase I Clinical Trial Update As announced on December 9,..

---

Research and Markets: China Disposable Vaccine Syringe Market Analysis 2009 is Vital Reading for those in the Medical and Pharmaceutical Industry
DUBLIN - Research and Markets(http://www.researchandmarkets.com/research/ed1690/china_disposable_v) has announced the addition of the China Disposable Vaccine Syringe Market Analysis 2009 report to their offering. China disposable vaccine syringe market analysis is an inv

---

NOVAVAX to Present at the 12th Annual BIO CEO & Investor Conference
ROCKVILLE, Md., Feb. 5 -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer of Novavax ...

---